Biological evaluation of boronated unnatural amino acids as new boron carriers

scientific article

Biological evaluation of boronated unnatural amino acids as new boron carriers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.APRADISO.2009.03.104
P932PMC publication ID2861333
P698PubMed publication ID19398346
P5875ResearchGate publication ID24365442

P2093author name stringS Chandra
G W Kabalka
M-L Yao
S R Marepally
P2860cites workQuantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: in vitro studies on human glioblastoma T98G cellsQ31053697
The Chemistry of Neutron Capture TherapyQ34114453
Boron neutron capture therapy of cancer: current status and future prospectsQ34423179
The radiation biology of boron neutron capture therapyQ34491960
The synthesis and use of boronated amino acids for boron neutron capture therapyQ36418029
Imaging intracellular elemental distribution and ion fluxes in cultured cells using ion microscopy: a freeze-fracture methodology.Q36481590
Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancerQ40060823
Subcellular imaging by dynamic SIMS ion microscopyQ40776293
Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitroQ40906700
Early history of development of boron neutron capture therapy of tumorsQ41470376
Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrinQ43549086
Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomographyQ44199240
Unilamellar liposomes with enhanced boron contentQ44493506
The syntheses and in vivo biodistribution of novel boronated unnatural amino acidsQ45016254
An investigation of boron neutron capture therapy for recurrent glioblastoma multiformeQ46735548
Uptake of two 10B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001).Q46912762
Positron Emission Tomography (PET) with 1-Aminocyclobutane-1-[11C]carboxylic Acid (1-[11C]-ACBC) for Detecting Recurrent Brain TumorsQ47597392
Blood-brain barrier transport of 1-aminocyclohexanecarboxylic acid, a nonmetabolizable amino acid for in vivo studies of brain transportQ48092972
The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanomaQ48309055
BNCT: Looking for a Few Good MoleculesQ48444469
Pathological study of eight patients with glioblastoma multiforme treated by neutron-capture therapy using boron 10.Q51337497
The Monte Carlo simulation of the biological effect of the 10B(n, alpha)7Li reaction in cells and tissue and its implication for boron neutron capture therapy.Q52593422
Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: Towards a novel therapy for liver metastasesQ59544249
Current status of 10B-neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluationQ70073429
Boron neutron capture therapy in the treatment of locally recurred head and neck cancerQ80773195
P433issue7-8 Suppl
P304page(s)S374-9
P577publication date2009-04-02
P1433published inApplied Radiation and IsotopesQ541448
P1476titleBiological evaluation of boronated unnatural amino acids as new boron carriers
P478volume67

Reverse relations

cites work (P2860)
Q38512169Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy
Q34995062Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas
Q89141802Boron delivery agents for neutron capture therapy of cancer
Q38101622Boronated carbohydrate derivatives as potential boron neutron capture therapy reagents
Q35103706Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy
Q21203116Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
Q33728100Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas
Q30475508Mass spectrometric imaging for biomedical tissue analysis
Q26995529Mass spectrometry imaging and profiling of single cells
Q35135541Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).

Search more.